Services - 211220-2020

Submission deadline has been amended by:  236255-2020
07/05/2020    S89

Netherlands-Amsterdam: Provision of External Service Providers for IT Software Development, Implementation and Maintenance Services for the Clinical Trials Information System

2020/S 089-211220

Contract notice

Services

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: European Medicines Agency
Postal address: PO Box 71010
Town: Amsterdam
NUTS code: NL1 NOORD-NEDERLAND
Postal code: 1008 BA
Country: Netherlands
E-mail: contracts@ema.europa.eu
Internet address(es):
Main address: https://www.ema.europa.eu/
Address of the buyer profile: https://www.ema.europa.eu/en/about-us/procurement
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: https://etendering.ted.europa.eu/cft/cft-display.html?cftId=6345
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted to the abovementioned address
I.4)Type of the contracting authority
European institution/agency or international organisation
I.5)Main activity
General public services

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Provision of External Service Providers for IT Software Development, Implementation and Maintenance Services for the Clinical Trials Information System

Reference number: EMA/2020/02/IT
II.1.2)Main CPV code
72000000 IT services: consulting, software development, Internet and support
II.1.3)Type of contract
Services
II.1.4)Short description:

This call for tender aims to put into place contractual arrangements with a maximum of three economic operators in priority order for the provision of services, on a time and means basis, quoted time and means or fixed price basis that will enable the Agency to acquire resources not employed directly by the Agency in the domain of IT software development, implementation and maintenance for the Clinical Trials Information System.

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.2)Additional CPV code(s)
72261000 Software support services
72262000 Software development services
72263000 Software implementation services
72265000 Software configuration services
72267000 Software maintenance and repair services
72232000 Development of transaction processing and custom software
II.2.3)Place of performance
NUTS code: NL1 NOORD-NEDERLAND
Main site or place of performance:

Services can be performed on an intra-muros or extra-muros basis.

Main site for intra-muros services is EMA premises, Domenico Scarlattilaan 6, Zuidas, Amsterdam, The NETHERLANDS.

II.2.4)Description of the procurement:

This call for tender aims to put into place contractual arrangements with a maximum of three economic operators in priority order for the provision of services, on a time and means basis, quoted time and means or fixed price basis that will enable the Agency to acquire resources not employed directly by the Agency in the domain of IT software development, implementation and maintenance for the clinical trials information system.

II.2.5)Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: yes
Description of renewals:

A maximum of three (3) framework contracts in priority order will be signed for an initial period of 24 months with two possible renewals, each for a period of 12 months, making a total possible contract duration of 4 years (2 + 1 + 1).

II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

See internet address provided in section I.3).

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

See internet address provided in section I.3).

III.1.2)Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:

See internet address provided in section I.3).

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
Envisaged maximum number of participants to the framework agreement: 3
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 26/06/2020
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
English, Bulgarian, Danish, German, Greek, Estonian, Finnish, French, Irish, Croatian, Hungarian, Italian, Latvian, Lithuanian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Spanish, Swedish, Czech
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
Duration in months: 12 (from the date stated for receipt of tender)
IV.2.7)Conditions for opening of tenders
Date: 29/06/2020
Local time: 14:00
Place:

European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, The NETHERLANDS.

Information about authorised persons and opening procedure:

See internet address provided in section I.3).

Section VI: Complementary information

VI.1)Information about recurrence
This is a recurrent procurement: yes
VI.3)Additional information:

See internet address provided in section I.3).

VI.4)Procedures for review
VI.4.1)Review body
Official name: General Court
Postal address: rue du Fort Niedergrünewald
Town: Luxembourg
Postal code: 2925
Country: Luxembourg
E-mail: generalcourt.registry@curia.europa.eu
Telephone: +352 4303-1
Fax: +352 4303-2100
Internet address: http://curia.europa.eu
VI.4.3)Review procedure
Precise information on deadline(s) for review procedures:

See internet address provided in section I.3).

VI.4.4)Service from which information about the review procedure may be obtained
Official name: European Medicines Agency
Postal address: PO Box 71010
Town: Amsterdam
Postal code: 1008 BA
Country: Netherlands
E-mail: info@ema.europa.eu
Telephone: +31 88781600
Internet address: https://www.ema.europa.eu
VI.5)Date of dispatch of this notice:
30/04/2020